Founded in 2019, Brexogen is at the forefront of biotechnological innovation, dedicated to transforming the treatment of incurable diseases through our proprietary BG-Platform technology. As a pioneering bioventure, we specialize in the development of cell-free therapies, leveraging the untapped potential of stem cell derived exosomes.
Our mission intertwines groundbreaking research with practical healthcare solutions. As we gear up for global expansion, our strategy emphasizes understanding local markets, forging strategic partnerships, continuous innovation, and engaging with the medical community to promote the benefits of exosome therapy.
Rooted in South Korea, Brexogen is on a trajectory to enhance healthcare outcomes worldwide. We're dedicated to leading the charge in biotechnological innovation, offering accessible, effective treatments on a global scale.
Join our journey as we strive for a healthier future across communities globally.
Company Details
- Employees
- 8
- Founded
- -
- Address
- 송파구 법원로8길9, 3층, 9층, 서울시,korea, Republic Of
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://brexogen.com/
- Keywords
- 바이오.
- HQ
- 서울시
Brexogen Inc. Questions
Brexogen Inc.'s website is http://brexogen.com/
Brexogen Inc.'s LinkedIn profile is https://kr.linkedin.com/company/brexogen-inc
Brexogen Inc. has
8 employees.
View email and phone details for 8
employees at Brexogen Inc..
Brexogen Inc.'s industry is
Biotechnology Research
Brexogen Inc.'s top competitors are
Direct Biologics,
Versatope Therapeutics,
Turn Biotechnologies,
Kcrn Research,
Coya Therapeutics, Inc.,
Bmi Korea,
Pohang Bio Industry Association (Pba),
Kimera,
Exogenus Therapeutics,
Gen Era Diagnostics.
Brexogen Inc.'s categories are Biotechnology Research
Brexogen Inc.'s founding year is 2019
